Presentation and analysis of radiographic data in clinical trials and observational studies

Annals of the Rheumatic Diseases

Volumn 64, Issue SUPPL. 4, 2005, Pages

  Landewe R ^a   Van Der Heijde, D ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HUMAN; IMAGING SYSTEM; JOINT RADIOGRAPHY; MONOTHERAPY; PRIORITY JOURNAL; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; HUMANS; PROBABILITY; TREATMENT OUTCOME;

EID: 27444447629     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.042572     Document Type: Conference Paper

References (13)

1. Landewé R, van der Heijde D. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 2004;50:699-706.
2. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
3. van der Heijde D, Landewe R. Imaging: do erosions heal? Ann Rheum Dis 2003;62(suppl 2):ii10-ii12.
4. Bruynesteyn K, Van Der Heijde D, Boers M, Soudan A, Peloso P, Paulus H, et al. Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence. J Rheumatol 2002;29:2306-12.
5. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al; TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
6. Bruynesteyn K, Landewe R, Van Der Linden S, Van Der Heijde D. Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months follow-up. Ann Rheum Dis 2004;63:1413-18 [Epub 22 March 2004].
7. van der Heijde D, Landewe R, Klareskog L, Rodriguez-Valverde V, Settas L, Pedersen R, et al. Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study. Arthritis Rheum 2005;52:49-60.
8. Plant MJ, Jones PW, Saklatvala J, Ollier WER, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study. J Rheumatol 1998;25:417-26.
9. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
10. Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
11. Welsing PM, Landewé RB, van Riel PL, Boers M, van Gestel AM, van der Linden S, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004;50:2082-93.
12. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
13. Landewé R, Geusens P, van der Heijde D, Sj van der Linden MB, Garnero P. Clinically perceptible arthritis instantaneously influences collagen type-I and type-II degradation in patients with early rheumatoid arthritis, a longitudinal analysis. Ann Rheum Dis (in press).